Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |